RPR107393 free base is an orally active potent selective squalene synthase (SQS) inhibitor. RPR107393 free base inhibits rat liver microsomal squalene synthase with an IC50 value of 0.8 nM. RPR107393 free base reduces triglyceride biosynthesis by suppressing fatty acid biosynthesis via an increase in intracellular farnesol and its derivatives. RPR107393 free base reduces plasma cholesterol in rats and marmosets. RPR107393 free base can be used for metabolic disease research, such as hypercholesterolemia, hypertriglyceridemia and atherosclerosis[1][2].
Molecular Weight:
330.42
CAS Number:
[197576-78-6]
Formula:
C22H22N2O
Target:
Farnesyl Transferase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted